VAERS reports by lot

GSK Varicella/Shingles lot 3HX44: VAERS reports

35 VAERS reports list lot 3HX44 as a GSK Varicella/Shingles vaccine, received between 2019-07-31 and 2021-07-26. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
35
Reports
6%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3933%
Dermatological (non-injection-site)2521%
General / Systemic (non-local)2319%
Neurological87%
Gastrointestinal87%
Musculoskeletal65%
Allergic / Anaphylactic54%
Respiratory22%
Cardiac / Cardiovascular11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California6
Alabama6
Florida4
New York3
Georgia2
Louisiana2
North Carolina2
Massachusetts1
Pennsylvania1
South Carolina1
Illinois1
Connecticut1

Reports by month received

2019-071
2019-0814
2019-095
2019-107
2019-112
2020-013
2020-111
2020-121
2021-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.